-transparent.png){kind=logo}
We have determined the alpha-thalassaemia (alpha-thal) determinants in 78 patients with Hb H disease from Cyprus; 25 were Turkish Cypriots and 53 were Greek Cypriots. Four deletional and three non-deletional alpha-thal alleles were present; the -alpha(3.7 kb) alpha-thal-2 and the --MED-I alpha-thal-1 were most frequently seen; --MED-II and -(alpha)20.5 deletions occurred at considerably lower frequencies. About 15% of all chromosomes carried a non-deletional alpha-thal-2 allele; of these the 5 nucleotide (nt) deletion at the first intervening sequence (IVS-I) donor splice site was present in approximately 8% of all chromosomes. Two types of polyadenylation signal (poly A) mutations were observed. No striking frequency differences were seen between Greek and Turkish Cypriot patients. Combinations of the various types of alpha-thal resulted in eight different forms of Hb H disease. The phenotypes were comparable except for great variations in the level of Hb H which was highest (average approximately 22%) in the 12 patients with the alpha 5nt alpha/--MED-I combination. One patient with the same form of Hb H disease but with an additional beta-thal (IVS-I-110,G-->A) heterozygosity had a most severe microcytosis and hypochromia with < 1% Hb H. Variations in the level of Hb H might correlate with the severity of the disease, although this was not evident from the haematological data.
E Baysal, and
M Kleanthous, and
G Bozkurt, and
A Kyrri, and
E Kalogirou, and
M Angastiniotis, and
P Ioannou, and
T H Huisman
October 1979,
Journal of medical genetics,
E Baysal, and
M Kleanthous, and
G Bozkurt, and
A Kyrri, and
E Kalogirou, and
M Angastiniotis, and
P Ioannou, and
T H Huisman
March 1983,
British journal of haematology,
E Baysal, and
M Kleanthous, and
G Bozkurt, and
A Kyrri, and
E Kalogirou, and
M Angastiniotis, and
P Ioannou, and
T H Huisman
August 1992,
British journal of haematology,
E Baysal, and
M Kleanthous, and
G Bozkurt, and
A Kyrri, and
E Kalogirou, and
M Angastiniotis, and
P Ioannou, and
T H Huisman
April 1973,
British medical journal,
E Baysal, and
M Kleanthous, and
G Bozkurt, and
A Kyrri, and
E Kalogirou, and
M Angastiniotis, and
P Ioannou, and
T H Huisman
August 1975,
Proceedings of the Royal Society of Medicine,
E Baysal, and
M Kleanthous, and
G Bozkurt, and
A Kyrri, and
E Kalogirou, and
M Angastiniotis, and
P Ioannou, and
T H Huisman
February 1981,
Lancet (London, England),
E Baysal, and
M Kleanthous, and
G Bozkurt, and
A Kyrri, and
E Kalogirou, and
M Angastiniotis, and
P Ioannou, and
T H Huisman
July 1986,
British journal of haematology,
E Baysal, and
M Kleanthous, and
G Bozkurt, and
A Kyrri, and
E Kalogirou, and
M Angastiniotis, and
P Ioannou, and
T H Huisman
October 1989,
British journal of haematology,
E Baysal, and
M Kleanthous, and
G Bozkurt, and
A Kyrri, and
E Kalogirou, and
M Angastiniotis, and
P Ioannou, and
T H Huisman
June 2007,
Medicine and law,
E Baysal, and
M Kleanthous, and
G Bozkurt, and
A Kyrri, and
E Kalogirou, and
M Angastiniotis, and
P Ioannou, and
T H Huisman
November 1986,
Human genetics,
